Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-04-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
5 public aid cases recorded, with a total value of $1,463,891.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 6, 2024 | Aid for research and development projects: experimental development | $668.6K$668,588 | Prezes Agencji Badań Medycznych | |
| Dec 6, 2024 | Aid for research and development projects: industrial research | $335.7K$335,655 | Prezes Agencji Badań Medycznych | |
| Mar 3, 2023 | Aid for SME access to finance — aid for start-ups | $199.9K$199,900 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The following is authorized to submit declarations of will on behalf of the company: 1. in the case of a one-person management board, the sole member of the management board acting independently; 2. in the case of a multi-member management board, if no member of the management board for financial matters (CFO) is appointed, two members of the management board jointly; 3. in the case of a multi-member management board, if a member of the management board for financial matters (CFO) is appointed, the member of the management board for financial matters jointly with another member of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 368 | $9,940.57 | 14.3191% | |
Łukasz Lebiedziński (50) | 1,101 | $27,309.56 | 39.3385% |
Jakub Paweł Szczerbuk (43) | 1,101 | $27,309.56 | 39.3385% |
Others | 194 | $4,862.24 | 7.0039% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Łukasz Lebiedziński (50)  | Shareholder of a limited liability company, 110100.0 PLN | |
Jakub Paweł Szczerbuk (43) | Shareholder of a limited liability company, 110100.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Therapiqsp. z o.o. | $7,482.34 | therapiq.eu | ||
| NEO Ortho Pracownia Sztuki Ortopedycznejsp. z o.o. | $5,662.74 | neoortho.pl | ||
| PD Medssp. z o.o. | $3,515.83 | pdmeds.com | ||
| Bioimplantisp. z o.o. | $1,660.39 | bioimplanti.pl | ||
| Royal Methodsp. z o.o. | $1,089.26 | royal-method.com | ||
| Hetaloxsp. z o.o. | $965.71 | hetalox.com | ||
| Telemedical InnovationsS.A. | $872.98 | telemedicalinnovations.com | ||
| Dentioscansp. z o.o. | $118.24 | dentioscan.pl | ||
| Mindhandsp. z o.o. | $0.78 | mindhand.pl | ||
| Bodyscopesp. z o.o. | $0.05 | bodyscope.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-31 | Share capital change (256,700.00 PLN → 257,000.00 PLN) | |
| 2025-07-31 | Name change (Tjle → Britescope) | |
| 2023-04-21 | Share capital change (220,000.00 PLN → 256,700.00 PLN) | |
| 2023-01-13 | Share capital change (6,000.00 PLN → 220,000.00 PLN) | |
| 2020-03-11 | Address change (Ul. Dworcowa 41a/2, 10-437, Olsztyn → Ul. Franciszka Barcza 58/U18, 10-685, Olsztyn) |
FAQ
Last updated: 2026-04-12